BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

644 related articles for article (PubMed ID: 29131246)

  • 21. Cytokine profiles and CD8+ T cells in the occurrence of acute and chronic hepatitis B.
    Xie S; Yang L; Bi X; Deng W; Jiang T; Lin Y; Wang S; Zhang L; Liu R; Chang M; Wu S; Gao Y; Hao H; Shen G; Xu M; Chen X; Hu L; Lu Y; Song R; Xie Y; Li M
    Front Immunol; 2022; 13():1036612. PubMed ID: 36353632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High L-Carnitine Levels Impede Viral Control in Chronic Hepatitis B Virus Infection.
    Gu S; Fu X; Ye G; Chen C; Li X; Zhong S; Tang L; Chen H; Jiang D; Hou J; Li Y
    Front Immunol; 2021; 12():649197. PubMed ID: 34234772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Programmed death-1 (PD-1) and PD-L1 expression during antiviral treatment of chronic hepatitis B].
    Xie DY; Lin BL; Chen FJ; Deng H; Chong YT; Zhang XH; Gao ZL
    Zhonghua Gan Zang Bing Za Zhi; 2010 Sep; 18(9):646-50. PubMed ID: 20943073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive value of interferon-gamma inducible protein 10 kD for hepatitis B e antigen clearance and hepatitis B surface antigen decline during pegylated interferon alpha therapy in chronic hepatitis B patients.
    Wang Y; Zhao C; Zhang L; Yu W; Shen C; Wang W; Zhen Z; Zhou J
    Antiviral Res; 2014 Mar; 103():51-9. PubMed ID: 24418572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tfh cell-mediated humoral immune response and HBsAg level can predict HBeAg seroconversion in chronic hepatitis B patients receiving peginterferon-α therapy.
    Zhang L; Zhang M; Li H; Chen Z; Luo A; Liu B; Chen M; Peng M; Ren H; Hu P
    Mol Immunol; 2016 May; 73():37-45. PubMed ID: 27037894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural History of Chronic Hepatitis B Virus Infection in Ahvaz City, Iran.
    Makvandi M; Soleimani Jelodar R; Samarbafzadeh A; Neisi N; Sharifi Z; Gholampour A; Masjedizadeh A; Shayesteh A
    Asian Pac J Cancer Prev; 2018 Aug; 19(8):2125-2129. PubMed ID: 30139211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis.
    Boni C; Janssen HLA; Rossi M; Yoon SK; Vecchi A; Barili V; Yoshida EM; Trinh H; Rodell TC; Laccabue D; Alfieri A; Brillo F; Fisicaro P; Acerbi G; Pedrazzi G; Andreone P; Cursaro C; Margotti M; Santoro R; Piazzolla V; Brunetto MR; Coco B; Cavallone D; Zhao Y; Joshi A; Woo J; Lau AH; Gaggar A; Subramanian GM; Massetto B; Fung S; Ahn SH; Ma X; Mangia A; Ferrari C
    Gastroenterology; 2019 Jul; 157(1):227-241.e7. PubMed ID: 30930022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Virological Determinants of Spontaneous Postpartum e Antigen Seroconversion and Surface Antigen Seroclearance in Pregnant Women Infected with Hepatitis B Virus.
    Hu Y; Feng Z; Liu J; Chen J; Zhang S; Zhou YH
    Arch Med Res; 2016 Apr; 47(3):207-13. PubMed ID: 27387022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TCRγδ(+)CD4(-)CD8(-) T cells suppress the CD8(+) T-cell response to hepatitis B virus peptides, and are associated with viral control in chronic hepatitis B.
    Lai Q; Ma S; Ge J; Huang Z; Huang X; Jiang X; Li Y; Zhang M; Zhang X; Sun J; Abbott WG; Hou J
    PLoS One; 2014; 9(2):e88475. PubMed ID: 24551107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T-bet expression in CD8+ T cells associated with chronic hepatitis B virus infection.
    Fan R; Lan Y; Chen J; Huang Y; Yan Q; Jiang L; Song S; Li Y
    Virol J; 2016 Jan; 13():14. PubMed ID: 26809262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of cytokines on spontaneous hepatitis B surface antigen seroconversion in chronic hepatitis B virus infection.
    Wu JF; Hsu HY; Chiu YC; Chen HL; Ni YH; Chang MH
    J Immunol; 2015 Jan; 194(2):690-6. PubMed ID: 25505294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD8
    Nandi M; Pal S; Ghosh S; Chakraborty BC; Dey D; Baidya A; Shil A; Chattopadhyaya S; Banerjee S; Santra A; Chowdhury A; Datta S
    Clin Sci (Lond); 2019 Sep; 133(17):1917-1934. PubMed ID: 31477625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decades after recovery from hepatitis B and HBsAg clearance the CD8+ T cell response against HBV core is nearly undetectable.
    Kefalakes H; Jochum C; Hilgard G; Kahraman A; Bohrer AM; El Hindy N; Heinemann FM; Verheyen J; Gerken G; Roggendorf M; Timm J
    J Hepatol; 2015 Jul; 63(1):13-9. PubMed ID: 25646888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers.
    Thompson AJ; Nguyen T; Iser D; Ayres A; Jackson K; Littlejohn M; Slavin J; Bowden S; Gane EJ; Abbott W; Lau GK; Lewin SR; Visvanathan K; Desmond PV; Locarnini SA
    Hepatology; 2010 Jun; 51(6):1933-44. PubMed ID: 20512987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between hepatitis B virus DNA levels and diagnostic tests for HBsAg, HBeAg, and PreS1-Ag in chronic hepatitis B.
    Liu X; Chen JM; Lou JL; Huang YX; Yan Y; Sun GZ; Li N
    Genet Mol Res; 2016 Jul; 15(2):. PubMed ID: 27421011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating PD-1
    Zhang L; Li H; Ren H; Hu P
    Mol Immunol; 2018 Nov; 103():270-278. PubMed ID: 30340072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical implications of hepatitis B surface antigen quantitation in the natural history of chronic hepatitis B virus infection.
    Tan Z; Li M; Kuang X; Tang Y; Fan Y; Deng G; Wang Y; He D
    J Clin Virol; 2014 Apr; 59(4):228-34. PubMed ID: 24529415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive factors for early HBeAg seroconversion in acute exacerbation of patients with HBeAg-positive chronic hepatitis B.
    Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    Gastroenterology; 2009 Feb; 136(2):505-12. PubMed ID: 19101558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum Hepatitis B Virus DNA, RNA, and HBsAg: Which Correlated Better with Intrahepatic Covalently Closed Circular DNA before and after Nucleos(t)ide Analogue Treatment?
    Gao Y; Li Y; Meng Q; Zhang Z; Zhao P; Shang Q; Li Y; Su M; Li T; Liu X; Zhuang H
    J Clin Microbiol; 2017 Oct; 55(10):2972-2982. PubMed ID: 28747369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pegylated-interferon alpha therapy for treatment-experienced chronic hepatitis B patients.
    Yeh ML; Peng CY; Dai CY; Lai HC; Huang CF; Hsieh MY; Huang JF; Chen SC; Lin ZY; Yu ML; Chuang WL
    PLoS One; 2015; 10(4):e0122259. PubMed ID: 25835020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.